Remove Doctors Remove Ethics Remove FDA
article thumbnail

New ethical guidance for paediatric clinical trials

European Pharmaceutical Review

The US Food and Drug Administration (FDA) have published initial guidance deliberating how ethical it is for children to take part in research trials. Thus, numerous drugs and medical devices approved and licensed by the FDA are missing essential paediatric-specific information on their product labels.

Ethics 98
article thumbnail

FDA sets out its thinking on protecting children in clinical trials

pharmaphorum

The FDA has published draft guidance giving its position on the ethical reasons for including children in clinical trials, and protecting them from harm. ” The post FDA sets out its thinking on protecting children in clinical trials appeared first on.

FDA 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharma Trends: Shaping the Future of Healthcare Marketing

Pharma Marketing Network

Imagine being able to predict how well a drug will perform in a specific market or which doctors are more likely to prescribe a new therapy. As laws evolve to cover digital advertising, pharma companies need to ensure that their marketing practices are transparent and ethical. That’s the power of AI in pharma.

article thumbnail

Selling to Physicians from a Physician’s Perspective

MedCepts

Doctors are natural skeptics. Remember, doctors were educated in scientific communities. Any doctor prescribing them to their patient knows that they could be placing their license at risk. In addition, it needs to be approved either by the FDA or other respective authorizing body.

article thumbnail

Pharmaceutical Marketing: Innovative Strategies for Pharma Teams

Pharma Marketing Network

Patient-Centric Marketing: Putting Patients First Pharma marketing is no longer just about doctors and decision-makers. In an industry where lives are at stake, marketing teams must prioritize transparency, ethical practices, and compliance to build lasting relationships. Patients now play a central role in the conversation.

article thumbnail

Microscopic Markets with Macroscopic ImpactCrafting personalized campaigns for small patient populations.

PM360

Regulatory Compliance and Ethical Considerations It may sound like an obvious statement, but to engage patient audiences as a commercial entity, someone needs to keep a regulatory eye on the program. Food & Drug Administration (FDA). It’s better to pay a good one than to receive a letter from the FDA.

article thumbnail

Generative AI: Healthcare Innovations and Legal Challenges

Nixon Gwilt Law

As we explore each area, you'll find out how these AI applications can impact the company you’re building and the potential legal and ethical hurdles you might face. Synthetic data can: Address the scarcity of quality data due to the sensitive nature of health records, issues related to consent, and legal and ethical restrictions.